Exyn Technologies CEO granted 109,000 stock options

Exyn Technologies, Inc. reported that director and Chief Executive Officer Torres Declet Brandon received a grant of stock options on August 3, 2026 to purchase 109,000 shares of common stock at an exercise price of $1.82 per share.

Rhea-AI Filing Summary

Exyn Technologies, Inc. reported that director and Chief Executive Officer Torres Declet Brandon received a grant of stock options on August 3, 2026 to purchase 109,000 shares of common stock at an exercise price of $1.82 per share. These options expire on August 3, 2036 and vest as follows: 25% of the shares vest on August 3, 2027 and the remaining shares vest in equal monthly installments, subject to Torres Declet Brandon continuing as a service provider through each vesting date. Following this award, the reporting person holds 109,000 stock options directly.

Insider Trade Summary

Grant/Award: 109,000 shares

Grant/Award 1 txn

Insider Torres Declet Brandon

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option F1	109,000	$0.00	$0.00

Holdings After Transaction: Stock Option — 109,000 contracts (Direct)

Footnotes (1)

1. F1. On August 3, 2026 (the "Grant Date"), the Reporting Person was granted stock options to purchase 109,000 shares of the Issuer's common stock. These options vest in accordance with the following schedule: 25% of the shares vest on August 3, 2027 and the remainder vests in equal monthly installments, subject to the Reporting Person continuing as a service provider through each such date.

Key Figures

Options Granted: 109,000 stock options Exercise Price: $1.82 per share Expiration Date: August 3, 2036 +2 more

5 metrics

Options Granted 109,000 stock options Grant to Torres Declet Brandon on August 3, 2026

Exercise Price $1.82 per share Exercise price for the granted stock options

Expiration Date August 3, 2036 Expiration of the granted stock options

Initial Vesting Portion 25% of shares Portion vesting on August 3, 2027

Underlying Shares 109,000 shares Common shares underlying the stock options

Key Terms

Stock Option, exercise price, vesting, monthly installments, +1 more

5 terms

Stock Option financial

"the Reporting Person was granted stock options to purchase 109,000 shares"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"stock options to purchase 109,000 shares of the Issuer's common stock"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"These options vest in accordance with the following schedule"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

monthly installments financial

"the remainder vests in equal monthly installments"

Monthly installments are regular, fixed payments made each month to gradually pay off a larger amount, such as a loan or purchase. Think of it like paying for a big item in small, manageable parts instead of all at once. For investors, understanding installment payments helps gauge how debts are structured and how they might affect financial stability or cash flow over time.

service provider financial

"subject to the Reporting Person continuing as a service provider"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock option grant did Exyn Technologies (EXYN) report for its CEO?

Exyn Technologies reported a grant of 109,000 stock options to director and Chief Executive Officer Torres Declet Brandon on August 3, 2026. The options have a $1.82 exercise price, expire on August 3, 2036, and vest over time subject to continued service.

What is the exercise price of the new Exyn Technologies (EXYN) CEO stock options?

The granted stock options carry an exercise price of $1.82 per share for Exyn Technologies common stock. This price is the amount payable per share upon exercise of the options, if and when they vest and are exercised in the future.

How do the Exyn Technologies (EXYN) CEO stock options vest?

The options vest with 25% of the shares on August 3, 2027, and the remaining shares vest in equal monthly installments. Vesting is conditioned on Torres Declet Brandon continuing as a service provider through each applicable vesting date.

When do the Exyn Technologies (EXYN) CEO stock options expire?

The stock options granted to Torres Declet Brandon expire on August 3, 2036. If any portion of the options remains unexercised by that date, those unexercised options will no longer be exercisable under the terms of the award.

How many Exyn Technologies (EXYN) options does the CEO hold after this grant?

After this award, Torres Declet Brandon directly holds 109,000 stock options for Exyn Technologies common stock. This figure reflects the total options reported as beneficially owned following the transaction on August 3, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 09:43 PM Accepted by SEC EDGAR 08/05/2026 - 09:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Torres Declet Brandon

(Last) (First) (Middle)

C/O EXYN TECHNOLOGIES, INC.,

2118 WASHINGTON AVENUE, SUITE 1000

(Street)

PHILADELPHIA PENNSYLVANIA 19146

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Exyn Technologies, Inc. [ EXYN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$1.82	08/03/2026		A		109,000		(1)	08/03/2036	Common Stock	109,000	$0	109,000	D

Explanation of Responses:

1. On August 3, 2026 (the "Grant Date"), the Reporting Person was granted stock options to purchase 109,000 shares of the Issuer's common stock. These options vest in accordance with the following schedule: 25% of the shares vest on August 3, 2027 and the remainder vests in equal monthly installments, subject to the Reporting Person continuing as a service provider through each such date.

	/s/ Brandon Torres Declet	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)